Pediatrix Medical GroupFRA:PDC -0.97%63 Net Margin % is 6.21% as of Mar. 2026, which is 22% above its 10-year median of 5.11. GuruFocus rates FRA:PDC with a GF Score™ of 63/100 and a GF Value™ of €11.23 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Pediatrix Medical Group ranks better than 75.3% on this metric.
The historical rank and industry rank for Pediatrix Medical Group's Net Margin % or its related term are showing as below:
FRA:PDC'
s Net Margin % Range Over the Past 10 Years
Min: -84.15 Med: 5.11 Max: 15.59
Current: 9.02
FRA:PDC's Net Margin % is ranked better than 75.3% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 2.885
vs FRA:PDC: 9.02
Pediatrix Medical Group (FRA:PDC) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Pediatrix Medical Group Net Margin % Related Terms
Pediatrix Medical Group Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PDC vs SGRY, ADUS, SNDA: Net Margin % Comparison
For the Medical Care Facilities subindustry, Pediatrix Medical Group's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pediatrix Medical Group Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's Net Margin % distribution charts can be found below:
* The bar in red indicates where Pediatrix Medical Group's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pediatrix Medical Group (FRA:PDC) has a Net Margin % of 6.21% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Pediatrix Medical Group and its competitors. This is 22% above median its historical median of 5.11. According to the industry distribution chart, Pediatrix Medical Group ranks #165 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 24.7%.
Is Pediatrix Medical Group's Net Margin % too high?
Pediatrix Medical Group's current Net Margin % of 6.21% is 22% above median its 10-year median of 5.11. The Healthcare Providers & Services industry median Net Margin % is 2.89. Pediatrix Medical Group's value of 6.21% is 115.3% above this industry median. Based on the distribution chart, Pediatrix Medical Group ranks #165 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Pediatrix Medical Group has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's Net Margin % compare to SGRY and ADUS?
According to the Healthcare Providers & Services industry distribution chart, Pediatrix Medical Group ranks #165 out of 668 companies for Net Margin %. This places Pediatrix Medical Group in the top 25% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.89. Pediatrix Medical Group's value of 6.21% is 115.3% above this benchmark. While the company's 10-year median is 5.11 vs. the industry median of 2.89, Pediatrix Medical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pediatrix Medical Group's current Net Margin % of 6.21% is 115.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Pediatrix Medical Group and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pediatrix Medical Group's current Net Margin % is 6.21%, which is 22% above median its own 10-year median of 5.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Pediatrix Medical Group (FRA:PDC) is currently considered Significantly Overvalued. The stock's GF Value™ is €11.23, compared to a current price of €20.40 — trading 81.7% above its estimated fair value. The current Net Margin % is 6.21%, which is 22% above median its 10-year median of 5.11 and 115.3% above the Healthcare Providers & Services industry median of 2.89. Pediatrix Medical Group's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Pediatrix Medical Group (FRA:PDC), the current Net Margin % is 6.21% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pediatrix Medical Group (FRA:PDC) Overvalued in 2026?
Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued.
The current stock price of €20.40 is trading 81.7% above its estimated GF Value™ of €11.23.
GuruFocus considers Pediatrix Medical Group to be Significantly Overvalued.
Key valuation signals for FRA:PDC:
Net Margin %: 6.21% (22% above median its 10-year median of 5.11)
GF Value™: €11.23 vs. price of €20.40 (81.7% above fair value)
Industry Position: 115.3% above the Healthcare Providers & Services median (#165 of 668)
No single metric tells the full story. See the FRA:PDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
63GF Score
Get the complete analysis for FRA:PDC
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PDC has been successfully added to your 
